Kayyem Jon Faiz — SEC insider filings
SEC reporting owner CIK 1366268. 38 insider filings on record with FilingPulse; latest filed 2026-09-23.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2021-06-08 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 15 legs across 7 filings — 640,434 shares, $9,215,803 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 38,000 shares, $1,066,883 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: purchase of 80,738 shares @ $17.90 ($1,445,210) in Inhibrx Biosciences, Inc., filed 2024-06-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | Director | 14 | 14 legs · 466,521 sh · $9,015,804 | — | 15 |
| Inhibrx, Inc. (INBX) | Director | 11 | — | 7 legs · 38,000 sh · $1,066,883 | 15 |
| BIODESIX INC (BDSX) | Director | 13 | 1 leg · 173,913 sh · $200,000 | — | 19 |
Insider filings — Kayyem Jon Faiz
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-23 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 5,000 @ $100 | EDGAR |
| 2026-09-18 | 4/A | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 5,000 @ $100 | EDGAR |
| 2026-09-08 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 5,000 @ $113.52 | EDGAR |
| 2026-06-04 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 5,443 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 68,621 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Inhibrx Biosciences, Inc. (INBX) | Gift (G): 90,000 @ $0 | EDGAR |
| 2024-12-17 | 4 | Inhibrx Biosciences, Inc. (INBX) | Gift (G): 500,000 @ $0 · Gift (G): 250,000 @ $0 · Gift (G): 250,000 @ $0 | EDGAR |
| 2024-12-06 | 4 | Inhibrx Biosciences, Inc. (INBX) | Gift (G): 52,000 @ $0 | EDGAR |
| 2024-11-22 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 34,843 @ $14.23 · Purchase (P): 34,843 @ $14.23 · Purchase (P): 18,750 @ $14.19 · Purchase (P): 18,750 @ $14.19 | EDGAR |
| 2024-06-24 | 4 | Inhibrx Biosciences, Inc. (INBX) | Gift (G): 89,050 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 | EDGAR |
| 2024-06-07 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 49,284 @ $17.23 · Purchase (P): 8,265 @ $17.89 | EDGAR |
| 2024-06-04 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 70,193 @ $16.14 · Purchase (P): 46,792 @ $16.61 · Purchase (P): 80,738 @ $17.90 · Purchase (P): 65,337 @ $17.44 · Purchase (P): 23,726 @ $18.24 | EDGAR |
| 2024-05-30 | 4 | Inhibrx Biosciences, Inc. (INXB) | Grant/award (A): 806,075 · Grant/award (A): 6,250 · Grant/award (A): 6,250 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Inhibrx, Inc. (INBX) | Disposition to issuer (D): 3,224,301 @ $30 · Disposition to issuer (D): 25,000 @ $30 · Disposition to issuer (D): 25,000 @ $30 · Disposition to issuer (D): 17,259 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 more | EDGAR |
| 2024-05-23 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 46,686 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 105,389 (derivative) @ $0 | EDGAR |
| 2023-08-07 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 6,172 @ $1.62 | EDGAR |
| 2023-05-30 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 28,873 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | BIODESIX INC (BDSX) | Option exercise (M): 145,833 · Option exercise (M): 145,833 (derivative) @ $0 | EDGAR |
| 2023-01-23 | 4 | Inhibrx, Inc. (INBX) | Sale (S): 9,500 @ $25.26 | EDGAR |
| 2023-01-05 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 4,878 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2022-12-22 | 4 | BIODESIX INC (BDSX) | Option exercise (M): 31,619 · Option exercise (M): 31,619 (derivative) @ $0 | EDGAR |
| 2022-12-22 | 4 | Inhibrx, Inc. (INBX) | Sale (S): 7,541 @ $26.87 · Sale (S): 1,959 @ $27.61 | EDGAR |
| 2022-11-22 | 4 | Inhibrx, Inc. (INBX) | Sale (S): 2,733 @ $29.33 · Sale (S): 6,767 @ $30.12 | EDGAR |
| 2022-11-21 | 4 | BIODESIX INC (BDSX) | Purchase (P): 173,913 @ $1.15 | EDGAR |
| 2022-10-24 | 4 | Inhibrx, Inc. (INBX) | Sale (S): 3,572 @ $29.39 · Sale (S): 5,928 @ $30.58 | EDGAR |
| 2022-08-25 | 4 | Inhibrx, Inc. (INBX) | Gift (G): 11,900 @ $0 | EDGAR |
| 2022-08-08 | 4 | Inhibrx, Inc. (INBX) | Gift (G): 3,400 @ $0 | EDGAR |
| 2022-08-02 | 4 | Inhibrx, Inc. (INBX) | Gift (G): 118,500 @ $0 · Gift (G): 25,000 @ $0 · Gift (G): 25,000 @ $0 | EDGAR |
| 2022-05-26 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-12-08 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 31,619 (derivative) @ $0 · Grant/award (A): 50,368 (derivative) @ $0 · Grant/award (A): 27,038 (derivative) @ $0 | EDGAR |
| 2021-06-08 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1366268 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs